CRD3874-SI
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CRD3874-SI, covering 2025-12-19 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML [Phase 1]